In the latest market close, McKesson (MCK) reached $585.24, with a +0.83% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.11%. Elsewhere, the ...
Beyond funding, McKesson Amplify also will provide resources, strategic support and other tools to help state pharmacy ...
BofA lowered the firm’s price target on McKesson (MCK) to $650 from $680 and keeps a Buy rating on the shares. Specialty will remain a key ...
McKesson shared that on Dec. 30, 2024, it closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian ...
McKesson (MCK) has recently been on ... Shares of this prescription drug distributor have returned -5.5% over the past month versus the Zacks S&P 500 composite's +0.8% change.
In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...